Therapy for Improving Vascular Function in Diabetes

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43HL075926-01
Agency Tracking Number: HL075926
Amount: $128,203.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solitcitation Year: 2004
Solitcitation Topic Code: N/A
Solitcitation Number: PHS2004-2
Small Business Information
ARGINOX PHARMACEUTICALS, INC.
ARGINOX PHARMACEUTICALS, INC., 120 CONSTITUTION DR, STE B, MENLO PARK, CA, 94025
Duns: N/A
Hubzone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 PAUL Lane
 (650) 324-5153
 PLANE@ARGINOX.COM
Business Contact
 KEN DRAZEN
Phone: (650) 324-5150
Email: KEN@JUVENTIS.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): ArgiNOx is a recently-formed Wisconsin-based biotech startup that seeks to develop novel therapies for cardiovascular and inflammatory conditions resulting from insufficient or excess nitric oxide (NO). In the cardi

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government